Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial - Sun, H; Dodick, DW; Silberstein, S; Goadsby, PJ; Reuter, U; Ashina, M (Lancet Neurol, 2016)